PCCS RESEARCH
Participating in multiple clinical trials is essential for PCCS Pulmonary Clinic as it allows us to stay at the forefront of medical research and innovation. By engaging in these trials, can offer our patients access to cutting-edge treatments and therapies may not yet be available through standard care. This involvement not only enhances patient outcomes but also contributes to the advancement of medical knowledge in the field of pulmonary health, ultimately benefiting the wider community.
We partner with both the Houston Methodist Research Institute and Axsendo Clinical Research Organization
Houston Methodist Research Institute Trials
Pulmonary Device Trials &
Lung Nodule Diagnosis Trial
Airflow 1 (COPD)
Rhesolve (Chronic Bronchitis)
ZEVR (Emphysema)
Nightengale (lung nodule diagnosis)
Medication Treament Trials
Aerify 1 (COPD)
Contact for information:
We are currently enrolling only in the NIGHTENALE lung nodule diagnosis trial at the Houston Methodist Research Institute. Several trials are in the approval process and should be enrolling soon. To be considered for enrollment in NIGHTENGALE or possible future trials in chronic cough, emphysema, or asthma please call Brooke Shope at 713-441-3248
PCCS Partnered Clinical Trials
We are proud to announce our partnership with Axsendo Clinical Research based right here in Houston, Texas
Contact: Jerry Bellamy 844-290-2273, houston@axsendoclinical.com
https://www.axsendoclinicalresearch.com/patients
​Currently Enrolling Trials:​
Suspire-1: A clinical trial evaluating the effects of the drug dextramipexole on patients with COPD
We are currently enrolling only in the SUSPIRE COPD trial in our Axsendo Research Section. Several trials are in the approval process and should be enrolling soon. To be considered for enrollment in SUSPIRE or possible future trials in COPD or Asthma please call Jerry Bellamy at 844-290-2273 or email at houston@axsendoclinical.com